News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
New Automated Tool Monitors Clinical Trial Reporting
Diana Kwon | Feb 22, 2018
The watchdog website FDAAA TrialsTracker names and shames human studies that breach the FDA’s requirements for reporting results.
How Toxic is the World’s Most Popular Herbicide Roundup?
Katarina Zimmer | Feb 7, 2018
Glyphosate, the active ingredient in Roundup, is designed to be toxic to plants, but scientists observe some untoward effects on animals in the lab.
EU Advisor Recommends Regulatory Exemption for Gene Editing
Catherine Offord | Jan 18, 2018
Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.
Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months
Catherine Offord | Dec 17, 2017
More than 200 people are on waiting lists for the $373,000 treatment as hospitals try to work around problems with insurers.
USDA Buys Animals from Farm It Reported for Animal Welfare Abuses
Katarina Zimmer | Nov 14, 2017
The federal agency has so far not taken any enforcement action against Ruby Fur Farm.
Mass Resignation from
’s Editorial Board
Catherine Offord | Nov 6, 2017
Nineteen researchers have stepped down after the journal decided not to retract a paper that they say plagiarized the work of a Johns Hopkins biomedical scientist.
Report: Security Lapses in Handling of Deadly Pathogens
Katarina Zimmer | Oct 31, 2017
A government report finds that laboratories in the U.S. that work with select agents such as Ebola and anthrax aren’t as secure as they should be.
WHO Cherry-Picked Data on Pesticide, Investigation Finds
Ashley P. Taylor | Oct 22, 2017
A group evaluating glyphosate’s cancer risk omitted evidence that the chemical is not carcinogenic.
Great Lakes Gray Wolf to Retain Endangered Status
Catherine Offord | Aug 2, 2017
A US Court of Appeals ruled that the Interior Department acted prematurely in removing the animals from the endangered species list.
New FDA Pathway to Accelerate Development of Cell Therapies
Jef Akst | May 22, 2017
Four products have already qualified for the regenerative medicine advanced therapy (RMAT) designation that provides extra interactions with the agency, and sooner.